Head to head for first-timers
CoreAge Rx vs Willow
CoreAge Rx and Willow both offer GLP-1 telehealth, but they make different trade-offs on how gentle the start is, honest pricing, real support and access. Here they are side by side on the Mama-Match Score — our first-timer rubric.
CoreAge Rx
Higher scoreRank #1 for first-timers · Grade A
Mama-Match
Best for: Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Visit CoreAge RxWillow
Rank #12 for first-timers · Grade B−
Mama-Match
Best for: Moms who want to see the price and know who will be treating them before handing over their details, and who live in one of the 36 states Willow serves.
Visit WillowThe verdict for a first step
CoreAge Rx edges out Willow on the Mama-Match Score, 94 to 81 (A vs B−). Moms who want a clear, honest first step — a real clinician instead of a questionnaire, a flat price, and the freedom to pause when life needs you to.
Willow is still a genuine option — one of the few that publishes both prices before any questionnaire and puts a name and a face to every prescribing doctor — with the real caveat that it only reaches 36 states and that the cost climbs with your dose. Weigh the six first-timer factors below against your own priorities.
Side by side on all six factors
Both providers judged on the same first-timer rubric — the higher side on each factor is marked. See the methodology.
Price, access and features
| Detail | CoreAge Rx | Willow |
|---|---|---|
| Mama-Match Score | 94/100 · A | 81/100 · B− |
| Overall rank | #1 | #12 |
| Semaglutide | $149/mo | $299/mo |
| Tirzepatide | $349/mo | $399/mo |
| Coverage | All 50 states | 36 states (not AL, AK, AR, DE, KS, LA, MS, ND, NM, RI, SD, UT, VT, WV) |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
Mama-Match
CoreAge Rx
Rank #1 · Grade A
What we like
- One flat monthly price, with no teaser rate that jumps after the first month — you know the number before you commit
- A clinician reads your history and will genuinely talk timing with you if you're postpartum, breastfeeding, or trying to conceive
- Semaglutide and tirzepatide in one account, so you and a clinician can choose — and switch — without starting over
The caveats
- Not the rock-bottom teaser price — a couple of marketplaces dangle a lower first-month number
- Compounded medication only, not FDA-approved brand-name Ozempic or Wegovy
- A general metabolic program, not a dedicated OB-GYN or hormone consult
Mama-Match
Willow
Rank #12 · Grade B−
What we like
- Publishes both prices ($299 semaglutide, $399 tirzepatide) openly, with no questionnaire in the way
- A public directory of doctors with each one's name and profile — very few competitors do this
- Sublingual semaglutide and tirzepatide tablets for anyone who doesn't want to inject
The caveats
- December 2025: after a challenge by Novo Nordisk, the National Advertising Division found Willow had not substantiated its compounded-semaglutide safety and efficacy claims and referred it to the FTC and state regulators (NAD case #7488). Willow reports discontinuing the claims since; the referral itself is a matter of record
- Only 36 states — it doesn't operate in AL, AK, AR, DE, KS, LA, MS, ND, NM, RI, SD, UT, VT or WV
- Cost “varies by dosage and prescription,” so $299 is a floor rather than a fixed rate
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Mama-Match Score. Prices, states and verification reflect what each provider disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the methodology. Prices change — confirm them on each provider’s site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Willow with the other providers we review for women.
Or browse the full comparison hub.